Literature DB >> 32398584

Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.

Khaled Moumneh1, Arsham Sheybani2, Ronald L Fellman3, David G Godfrey3, Davinder S Grover3.   

Abstract

This is a descriptive case series of 3 patients with uncontrolled intraocular pressure that developed reticular corneal changes after initiating netarsudil (0.02%). In all cases, upon observing reticular corneal edema, netarsudil (0.02%) was stopped followed by disappearance of corneal honeycombing. With the increasing use of this novel glaucoma medication, potentially more rare side effects will be observed. Reticular corneal edema or corneal honeycombing is an ocular examination finding that can rarely occur after initiating netarsudil (0.02%) regardless of prior corneal edema status. In our experience, the reticular changes resolve upon cessation of netarsudil.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32398584     DOI: 10.1097/IJG.0000000000001516

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  5 in total

1.  Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.

Authors:  Lauren J Jeang; Ankit S Shah; Jon D Hammer; Sonal S Tuli
Journal:  Digit J Ophthalmol       Date:  2022-06-27

2.  Netarsudil-associated reticular corneal epithelial edema.

Authors:  Jennifer A Tran; Ula V Jurkunas; Jia Yin; Emma C Davies; David A Sola-Del Valle; Teresa C Chen; Michael M Lin
Journal:  Am J Ophthalmol Case Rep       Date:  2022-01-20

3.  "Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost".

Authors:  David Chung; Edward J Meier
Journal:  Am J Ophthalmol Case Rep       Date:  2022-03-25

Review 4.  Newer advances in medical management of glaucoma.

Authors:  Neethu Mohan; Arup Chakrabarti; Nazneen Nazm; Rajvi Mehta; Deepak P Edward
Journal:  Indian J Ophthalmol       Date:  2022-06       Impact factor: 2.969

5.  Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.

Authors:  Mona Bhargava; Surajit Sen; Varsha Bhambhani; Raj Shekhar Paul; Chandana Dutta
Journal:  Indian J Ophthalmol       Date:  2022-04       Impact factor: 2.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.